- 全部删除
- 您的购物车当前为空
GDC-0276, a potent, selective, reversible, and orally active NaV1.7 inhibitor with an IC50 value of 0.4 nM, offers potential for pain treatment while overcoming limitations associated with current pain medications, including addiction and off-target side effects. It is well tolerated and demonstrates a favorable pharmacokinetic profile.
为众多的药物研发团队赋能,
让新药发现更简单!
GDC-0276, a potent, selective, reversible, and orally active NaV1.7 inhibitor with an IC50 value of 0.4 nM, offers potential for pain treatment while overcoming limitations associated with current pain medications, including addiction and off-target side effects. It is well tolerated and demonstrates a favorable pharmacokinetic profile.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 3,330 | 5日内发货 | |
5 mg | ¥ 4,440 | 5日内发货 | |
25 mg | ¥ 11,700 | 6-8周 | |
50 mg | ¥ 15,300 | 6-8周 | |
100 mg | ¥ 19,500 | 6-8周 |
产品描述 | GDC-0276, a potent, selective, reversible, and orally active NaV1.7 inhibitor with an IC50 value of 0.4 nM, offers potential for pain treatment while overcoming limitations associated with current pain medications, including addiction and off-target side effects. It is well tolerated and demonstrates a favorable pharmacokinetic profile. |
靶点活性 | Nav1.7 electrophysiology:0.4 nM |
体内活性 | GDC-0276 is not detected in urine;?however, metabolites in urine were enriched in 14C with observed specific activities of 19.6 μCi/mg.e.GDC-0276 (oral adminstration; 0.5-5 mg/kg) shows enrichment of 14C with observed specific activities of 22.6 μCi/mg. |
分子量 | 462.58 |
分子式 | C24H31FN2O4S |
CAS No. | 1494581-70-2 |
密度 | 1.39 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容